Hurley Capital, LLC Rebus Holdings, Inc. Call Options Transaction History

Hurley Capital, LLC

  • $143 Billion
  • Q2 2025

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding RBSH

# of Institutions
2
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Rebus Holdings, Inc.

RBSH Quotes by TradingView
  • Ticker RBSH
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,900
  • Description
  • Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
More about RBSH
Track This Portfolio

Track Hurley Capital, LLC Portfolio

Follow Hurley Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hurley Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hurley Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email